THEOLYTICS
LIVE

Serial Number

88289439

Owner

Theolytics Ltd

Attorney

Rebecca Liebowitz

Filing Date

Feb 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

THEOLYTICS Trademark

Serial Number: 88289439 • Registration: 6139090

THEOLYTICS is a trademark filed by Theolytics Ltd on February 5, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Theolytics Ltd

Oxford OX37FY , GB

Entity Type: 99

Trademark Details

Filing Date

February 5, 2019

Registration Date

September 1, 2020

Published for Opposition

June 16, 2020

Goods & Services

Medical and veterinary preparations for use in the detection and treatment of cancer and cancer indications; medical and veterinary preparations, namely, vaccines; medical and veterinary preparations, namely, gene therapies; medical and veterinary preparations being anti-virals; biological preparations for the treatment of cancer and cancer indications; reagents, diagnostics and therapeutic preparations for use in the treatment of various cancers and cancer indications; viruses for therapeutic purposes, namely, for the treatment of cancer and cancer indications; viruses for therapeutic purposes, namely, for gene therapy and antivirals; viruses for therapeutic purposes, namely, as vaccines; oncolytic viral therapies; biological therapies for use in treatment of cancer and cancer indications; biological therapies for use as vaccines; biological therapies for use in gene therapy; biological therapies for use as anti-virals; pharmaceutical preparations for use in oncology

Chemicals used in science; biological preparations for use in science; biochemicals, namely, viruses, reagents, proteins, assays, catalysts, antibodies, polypeptides, precursors, nucleic acid sequences for research use; biochemicals based on viruses for scientific or research use

Medical and pharmacological research services; research and development services in the field of oncology; oncology research; medical research; development of therapies for treating cancer and cancer indications; research into the use of viruses in the treatment of diseases; consultancy relating to the research and development in the field of therapeutics; research and testing services in the field of virology

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 23, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2019 GNFN
FINAL REFUSAL E-MAILED
Oct 28, 2019 GNFR
FINAL REFUSAL WRITTEN
Oct 28, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2019 CRFA
ASSIGNED TO LIE
Oct 3, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2019 NWOS
NEW APPLICATION ENTERED
Feb 8, 2019 NWAP